AbbVie registers Phase 1 PK study of trosunilimab given IV and SC in healthy adultsNov 13Weekly roundup, 8 itemsABBV-295ABBV-722
AbbVie posts KEEPsAKE 2 update; registers pediatric vitiligo and real-world MIRV studiesOct 29Weekly roundup, 7 itemsABBV-706ABBV-722Updated
AbbVie posts results for Japan CLL/SLL study; also files new Phase 3 NSCLC trial vs pembrolizumabOct 23Weekly roundup, 6 itemsABBV-1480AbbVieUpdated
Pfizer registers four studies: elranatamab, berobenatide, tilrekimig, and completed etrasimod trialOct 23Weekly roundup, 14 itemsabrocitinibatirmociclibUpdated
AbbVie's CANASA label update and ABBV-253 trial recruitment lead busy week of registry changesOct 16Weekly roundup, 9 itemsABBV-1042ABBV-253Updated
Boehringer Ingelheim posts Brightline-2 brigimadlin results; BI 4060107 trial recruitsOct 15Weekly roundup, 5 itemsBoehringer Ingelheimempagliflozin
AbbVie's AGN-151586 Phase 2 forehead lines study completes enrollment; four more trials registeredOct 8Weekly roundup, 5 itemsAbbVieAGN-151586Updated
AbbVie registers Phase 1 trial comparing upadacitinib, tofacitinib, baricitinib in healthy adultsSep 30Weekly roundup, 4 itemsABBV-722AbbVie
AbbVie posts results from terminated emraclidine trial, opens two studies to recruitmentAug 21Weekly roundup, 4 itemsAbbVieemraclidine
AbbVie posts Crohn's OLE results; registers Phase 3 lung cancer and Phase 1 glabellar lines trialsAug 13Weekly roundup, 3 itemsABBV-1480AbbVie
AbbVie registers three new trials spanning obesity, head and neck cancer, and atopic dermatitisAug 7Weekly roundup, 3 itemsABBV-295AbbVie
AbbVie to acquire Apogee Therapeutics, updates 2026 EPS guidance amid Q2 resultsJul 31Quarterly updateAbbVie